Home » Archive

Articles Archive for Year 2014

Opinion»

[ by | Dec 31, 2014 1:04 pm | 17 Comments ]
Myeloma Lessons: I Have A Dream Too

Dr. Martin Luther King, Jr. had a “Dream.” In perhaps the most inspiring and powerfully delivered speech of our generation, he outlined his ambitious goal of equality for all.

I have a dream too, although mine is far less encompassing – and decidedly more self-centered – than Dr. King’s.

For many years, my dream was pretty simple: live to the ripe old age of 93, surrounded by scads of grandkids and great grandkids. Live an active life right up to the end.

And then the doctor came into my hospital …

Read the full story »

Opinion»

[ by | Dec 28, 2014 3:57 pm | 3 Comments ]
Myeloma, Party Of Two: My Christmas Gift

With children’s choirs clad in red and green singing round nativity scenes, eager shoppers filling the stores, and lines leading to knee-weary Santas, I've been thinking: What is the perfect Christmas gift this season?

At various points in my life, I definitely would have answered that question differently.

There were countless Christmas mornings when I awoke wide-eyed, hoping to see the fruits of the “nice list” rather than the “naughty” one.

As a little girl, I adored Princess Leia from Star Wars.  Santa really rocked my world one year with …

Read the full story »

Press Releases»

[ by | Dec 26, 2014 7:00 am | Comments Off ]
  • Approval is being sought for use as a high-dose conditioning treatment prior to stem cell transplantation in multiple myeloma and for the palliative treatment of patients with multiple myeloma for whom oral therapy is not appropriate.
  • The Company expects FDA review to take approximately 10 months.
  • The Company plans to launch this drug with its existing hematology/oncology sales force next year pending approval.
  • Our formulation is free of propylene glycol and does not use a

 …

Read the full story »

Holiday»

[ by | Dec 25, 2014 5:50 am | 10 Comments ]
Happy Holidays!

As the 2014 holiday season reaches it peak, all of us here at The Myeloma Beacon would like to thank you, our readers and members of the Beacon community, for giving us the greatest gift possible: your time. 

We appreciate your coming to The Beacon and reading our articles, letting us know your thoughts about them, and sharing your experiences and helping one another in our forums.

The holiday season is a time of many different traditions. It also is a busy time, when it is easy to lose track of …

Read the full story »

Opinion»

[ by | Dec 23, 2014 2:52 pm | 8 Comments ]
Myeloma Mom: Eat The Fudge

Shortly before Thanksgiving, I started seeing my Facebook news feed fill up with articles about how to make healthy food choices during the holiday season. How to avoid weight gain. Why cookies will kill you, and why you need to step away from the eggnog and head to the gym.

I started seeing friends complain about the size of their thighs. They revealed the crushing guilt they feel from having that extra serving of mashed potatoes. They acknowledged that they’re suffering emotional damage from taste-testing the sugar-cookie dough.

And I …

Read the full story »

Opinion»

[ by | Dec 19, 2014 6:49 pm | 17 Comments ]
Myeloma In Paradise: It’s A Matter Of Perspective

I struggled mightily with my column this month. I started, stopped, started again, and finally gave up on a half-finished story that seemed relevant at the begin­ning, but eventually got mired in minutiae that my heart just wasn’t into.

What struck me was that the things that were important a few weeks ago when I started to write seemed exceptionally trivial just a short time later.

What changed?

My perspective.

You see, during this period I was touched by the situations some of our fellow patients are in …

Read the full story »

Press Releases»

[ by | Dec 19, 2014 8:10 am | Comments Off ]
Celgene Receives Positive CHMP Opinion To Extend Revlimid (Lenalidomide) For Continuous Use In Patients With Newly Diagnosed Multiple Myeloma And Ineligible For Transplant

Boudry, Switzerland (Press Release) – Celgene Inter­na­tional Sàrl, a wholly owned sub­sid­i­ary of Celgene Corpo­ra­tion (NASDAQ: CELG), today announced that the European Medicines Agency's (EMA) Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for continuous oral treat­ment with REVLIMID® in adult patients with pre­vi­ously untreated multiple myeloma who are not eli­gible for stem cell trans­plan­ta­tion.

The CHMP reviews appli­ca­tions for all 28 member states in the European Union (EU), as well as Norway, Liechtenstein and Iceland. The European Com­mis­sion, which generally follows the recom­men­da­tion of the CHMP, is ex­pec­ted to make its final de­ci­sion …

Read the full story »